Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michel Mittelbronn

Showing results (1-10 of 298) with videos related to

Pageof 30
Sort By:
Free Neuropathology|October 10, 2024
Neurooncology: 2024 updateMichel Mittelbronn
Free Neuropathology|June 7, 2023
Neurooncology: 2023 updateMichel Mittelbronn
Free Neuropathology|April 2, 2025
Neurooncology: 2025 updateMichel Mittelbronn
Anti-Cancer Agents in Medicinal Chemistry|October 1, 2010
Therapeutic exploitation of apoptosis and autophagy for glioblastomaDonat Kögel, Simone Fulda, Michel Mittelbronn
Acta Neuropathologica|February 22, 2005
Redistribution of the water channel protein aquaporin-4 and the K+ channel protein Kir4.1 differs in low- and high-grade human brain tumorsArne Warth, Michel Mittelbronn, Hartwig Wolburg
Neuro Endocrinology Letters|May 2, 2006
Atypical pituitary adenoma exhibiting densely secretory granules and basophilia without hormone productionMichel Mittelbronn, Richard Meyermann, Jürgen Honegger
Muscle & Nerve|October 4, 2007
Myogenesis in human denervated muscle biopsiesKathrin Doppler, Michel Mittelbronn, Antje Bornemann
Neuro-Oncology|June 21, 2015
Towards an unbiased, collaborative effort to reach evidence about the presence of human cytomegalovirus in glioblastoma (and other tumors)Martin Michaelis, Michel Mittelbronn, Jindrich Cinatl
Frontiers in Immunology|August 31, 2018
Microglia in Health and Disease: A Unique Immune Cell PopulationAlessandro Michelucci, Michel Mittelbronn, Diego Gomez-Nicola
Acta Neuropathologica|October 30, 2007
Pitfalls in the assessment of MGMT expression and in its correlation with survival in diffuse astrocytomas: proposal of a feasible immunohistochemical approachDavid Capper, Michel Mittelbronn, Richard Meyermann, et al.
Pageof 30

Showing results (1-10 of 298) with videos related to

Sort By:
Pageof 30
Free Neuropathology|October 10, 2024
Neurooncology: 2024 updateMichel Mittelbronn
Free Neuropathology|June 7, 2023
Neurooncology: 2023 updateMichel Mittelbronn
Free Neuropathology|April 2, 2025
Neurooncology: 2025 updateMichel Mittelbronn
Anti-Cancer Agents in Medicinal Chemistry|October 1, 2010
Therapeutic exploitation of apoptosis and autophagy for glioblastomaDonat Kögel, Simone Fulda, Michel Mittelbronn
Acta Neuropathologica|February 22, 2005
Redistribution of the water channel protein aquaporin-4 and the K+ channel protein Kir4.1 differs in low- and high-grade human brain tumorsArne Warth, Michel Mittelbronn, Hartwig Wolburg
Neuro Endocrinology Letters|May 2, 2006
Atypical pituitary adenoma exhibiting densely secretory granules and basophilia without hormone productionMichel Mittelbronn, Richard Meyermann, Jürgen Honegger
Muscle & Nerve|October 4, 2007
Myogenesis in human denervated muscle biopsiesKathrin Doppler, Michel Mittelbronn, Antje Bornemann
Neuro-Oncology|June 21, 2015
Towards an unbiased, collaborative effort to reach evidence about the presence of human cytomegalovirus in glioblastoma (and other tumors)Martin Michaelis, Michel Mittelbronn, Jindrich Cinatl
Frontiers in Immunology|August 31, 2018
Microglia in Health and Disease: A Unique Immune Cell PopulationAlessandro Michelucci, Michel Mittelbronn, Diego Gomez-Nicola
Acta Neuropathologica|October 30, 2007
Pitfalls in the assessment of MGMT expression and in its correlation with survival in diffuse astrocytomas: proposal of a feasible immunohistochemical approachDavid Capper, Michel Mittelbronn, Richard Meyermann, et al.
Pageof 30